Emtricitabine(FTC), with trade nameEmtriva(formerlyCoviracil), is a nucleoside reverse transcriptase inhibitor(NRTI) for the treatment ofHIVinfection in adults and children.
Emtricitabine is also marketed in a fixed-dose combination with tenofovir(Viread) under the brand nameTruvada.
A fixed-dose triple combination of emtricitabine, tenofovir, and efavirenz(Sustiva, marketed byBristol-Myers Squibb) was approved by theU.S. Food and Drug Administration(FDA) on July 12, 2006, under the brand nameAtripla.
It is on theWorld Health Organization's List of Essential Medicines, a list of the most important medication in a basic health system.
|Packaging Size||30 Tablets|
|Dose/Strength (ex. 1 mg or 1 ml)||Emtricitabine(200 Mg), Tenofovir(300 Mg)|
|Pack size||30 TAB|
|Composition||TENOFOVIR DISOPROXIL FUMARATE AND EMTRICITABINE|